Clinical Trials Directory

Trials / Completed

CompletedNCT06103994

Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

A Randomized, Triple-blinded, Placebo-controlled, Parallel Group Study, to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
The Archer-Daniels-Midland Company · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A randomized, triple-blinded, placebo-controlled, parallel group study, to assess the effect of multistrain probiotic on the immune response to the Influenza vaccination

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMultistrain probioticMultistrain Probiotic
OTHERPlaceboPlacebo

Timeline

Start date
2023-10-27
Primary completion
2024-01-12
Completion
2024-01-12
First posted
2023-10-27
Last updated
2025-04-10

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06103994. Inclusion in this directory is not an endorsement.

Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination (NCT06103994) · Clinical Trials Directory